General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: A cross-sectional study in 2007

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Lu, Jian ^a   Zhou, Yongdong ^a   Lin, Xiaojing ^a   Jiang, Yongzhen ^a   Tian, Ruiguang ^a   Zhang, Yonghui ^a   Wu, Jia ^a   Zhang, Fengwei ^a   Zhang, Yong ^a   Wang, Yue ^a   Bi, Shengli ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; HEPATITIS A ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HEPATITIS E ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CHINA; CROSS-SECTIONAL STUDY; DISEASE COURSE; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS E; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; VACCINATION; VIRUS CARRIER;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; GEOGRAPHY; HEPACIVIRUS; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VIRUS, HUMAN; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS, VIRAL, HUMAN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS E VIRUS;

EID: 77954046578     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008467     Document Type: Article

References (38)

1. Kuiken T, Fouchier R, Rimmelzwaan G, Osterhaus A (2003) Emerging viral infections in a rapidly changing world. Current Opinion in Biotechnology 14: 641-646.
2. David MM, Gregory KF, Anthony SF (2008) Emerging infections: a perpetual challenge. Lancet Infect Dis 8: 710-719.
3. Writing Committee of the Second World Health Organization (2008) Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus. N Engl J Med 358: 261-273.
4. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
5. Purcell RH (1994) Hepatitis viruses: changing patterns of human disease. Proc Natl Acad Sci U S A 91: 2401-2406.
6. Degertekin B, Lok AS (2008) Update on viral hepatitis: 2007. Curr Opin Gastroenterol 24: 306-311. Review.
7. Lok AS, Heathcote EJ, Hoofnagle JH (2001) Management of hepatitis B: 2000- summary of a workshop. Gastroenterology 120: 1828-1853. Review.
8. Hoofnagle JH (1998) Therapy of viral hepatitis. Digestion 59: 563-78. Review.
9. Emerson SU, Purcell RH (2007) Hepatitis E. Pediatr Infect Dis J 26: 1147-1148. Review.
10. Martin A, Lemon SM (2006) Hepatitis A virus: from discovery to vaccines. Hepatology 43: S164-172.
11. Cao J, Wang Y, Song H, Meng Q, Sheng L, et al. (2009) Hepatitis A outbreaks in China during 2006: application of molecular epidemiology. Hepatol Int 3: 356-63.
12. World Health Organization: Hepatitis A. Available: http://www.who.int/ mediacentre/factsheets/fs328/en/ Accessed 27 April, 2009.
13. Centers for Disease Control and Prevention: Surveillance Summaries. Surveillance for Acute Viral Hepatitis -United States, 2006. MMWR 2008; 57: SS-2.
14. World Health Organization. Hepatitis E. WHO/CDS/CSR/EDC/2001.12.
15. World Health Organization: Hepatitis E. Available: http://www.who.int/ mediacentre/factsheets/fs280/en/ Accessed 27 April, 2009.
16. Mushahwar IK (2008) Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 80: 646-658. Review.
17. Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr, Thapa GB, et al. (2007) Safety and Efficacy of a Recombinant Hepatitis E Vaccine. N Engl J Med 356: 895-903.
18. World Health Organization: Hepatitis B. Available: http://www.who.int/ mediacentre/factsheets/fs204/en/ Accessed 27 April, 2009.
19. Lok AS, McMahon BJ (2007) Chronic Hepatitis B. Hepatology 45: 507-539.
20. Mohanty SR, Kupfer SS, Khiani V (2006) Nat Clin Pract Gastroenterol Hepatol. 3: 446-458. Review.
21. Liang X, Bi S, Yang W, Wang L, Cui G, et al. (2009) Evaluation of the Impact of Hepatitis B Vaccination among Children Born during 1992-2005 in China. J Infect Dis 200: 39-47.
22. World Health Organization: Hepatitis C. Available: http://www.who.int/ mediacentre/factsheets/fs164/en/ Accessed 27 April, 2009.
23. Raimondo G, Saitta C (2008) Treatment of the hepatitis B virus and hepatitis C virus co-infection: Still a challenge for the hepatologist. Journal of Hepatology 49: 677-679.
24. Lin X, Zhang Y, Bi S, Lu J, Zhao H, et al. (2009) Hepatitis C virus envelope glycoproteins complementation patterns and the role of the ecto- and transmembrane domains. Biochem Biophys Res Commun 385: 257-262.
25. Wang Y, Kato N, Jazag A, Dharel N, Otsuka M, et al. (2006) Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. Gastroenterology 130: 883-892.
26. Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, et al. (2003) Interleukin- 1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37: 65-71.
27. Wang Y, Kato N, Hoshida Y, Otsuka M, Taniguchi H, et al. (2004) UDP- glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in Japanese patients with hepatitis C virus infection. Clin Cancer Res 10: 2441-2446.
28. Liao G, Wang Y, Chang J, Bian T, Tan W, et al. (2008) Hepatitis B virus precore protein augments genetic immunizations of the truncated hepatitis C virus core in BALB/c mice. Hepatology 47:25-34. Erratum in: Hepatology. 2008 Jun; 47(6): 2149.
29. Deng Y, Zhang K, Tan W, Wang Y, Chen H, et al. (2009) A recombinant DNA and vaccinia virus prime-boost regimen induces potent long-term T-cell responses to HCV in BALB/c mice. Vaccine 27: 2085-2088.
30. Jiang YZ, Lu J, Zhang LP, Tian RG, Liu QL, et al. (2008) Antibody detection and sequencing analysis of hepatitis E virus in human population, swine and chicken in Sichuan region in China. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 22: 468-471. Chinese.
31. Dai ZC, Qi GM (1997) Viral Hepatitis in China, Seroepidemiological Survey in Chinese Population (Part One) 1992-1995. Beijing: Beijing Science and Technology Press. pp 39-58.
32. NIH Consensus Statement on Management of Hepatitis C:2002. NIH Consensus and State-of-the-Science Statements. Volume 19, Number 3, June 10-12, 2002.
33. Yuen MF, Hou JL, Chutaputti A (2009) Hepatocellular carcinoma in the Asia pacific region. Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma. J Gastroenterol Hepatol 24: 346-353. Review.
34. Purcell RH, Emerson SU (2008) Hepatitis E: an emerging awareness of an old disease. J Hepatol 48: 494-503. Review.
35. Grassly NC, Fraser C (2008) Mathematical models of infectious disease transmission. Nat Rev Microbiol 6: 477-487.
36. Huang FF, Sun ZF, Emerson SU, Purcell RH, Shivaprasad HL, et al. (2004) Determination and analysis of the complete genomic sequence of avian hepatitis E virus (avian HEV) and attempts to infect rhesus monkeys with avian HEV. J Gen Virol 85: 1609-1618.
37. Engle RE, Yu C, Emerson SU, Meng XJ, Purcell RH (2002) Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay. J Clin Microbiol 40: 4576-4580.
38. Halbur PG, Kasorndorkbua C, Gilbert C, Guenette D, Potters MB, et al. (2001) Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J Clin Microbiol 39: 918-923.